Carbon reporting built for US pharma manufacturers
US CDMOs face EU client ESG requirements, California SB 253/261, and parent-group carbon mandates. Greenly gives you the data your supply chain is demanding.
TRUSTED BY 3,500 CLIENTS, FROM SMB TO ENTERPRISE
Why pharma reporting falls apart
Multi-site data, manual work
Scope 1/2 across 5–30 sites means months of manual work. Each location: different energy mixes, boundaries, local formats.
NHS approved list is at risk
NHS Net Zero Supplier Roadmap now requires GHG disclosure to stay on the approved supplier list. The next procurement round is already live.
Packaging LCAs: no baseline
PPWR and ESPR require LCA for pharma packaging. Product integrity limits what you can redesign. Most have no methodology
STEP 1Consolidate carbon data across plants
Each site reports into one structure; boundaries, energy mixes, and EFs set once, applied across the network.- Group dashboard shows consolidated Scope 1/2 with site-level drill-down.
- Supports M&A boundary changes without restarting the calculation.
STEP 2Pull primary data from your suppliers
- Automated supplier questionnaires with scoring, evidence capture, and audit trail — for Scope 3 cat 1 closing.
- Ecoinvent, ADEME, DEFRA, IEA, and EPA emission factor libraries with automated matching.
- Custom EF integration for client-specific or proprietary factors.
STEP 3Run your LCAs
- Model pharma packaging within product integrity constraints, not against idealized eco-design alternatives.
- ISO 14067-aligned output feeds directly into your corporate GHG footprint.
- Produces the evidence PPWR and ESPR auditors require.
STEP4Generate audit-ready outputs
- GHG Protocol Corporate Standard + Scope 3 Standard: the primary framework for hospital and parent-group compliance.
- CSRD ESRS E1 module. CDP and EcoVadis exports. NHS-compatible GHG disclosure.
- Auditor read-only mode. Version history per data point. No sprint preparation needed.
COMPLY WITH THE WORLD’S TOP STANDARDS
Frequently Asked Questions
Still have questions? Check out our complete FAQs to get the answers you’re looking for.
Yes. Greenly's multi-entity architecture supports group-level rollup with site-level granularity. Each manufacturing site can be configured with its own boundary, energy mix, and emission factor set, while the group dashboard aggregates them into a single report. This setup is in production for networks of 10 to 30 sites across multiple countries.
Yes. Greenly produces ISO 14067-aligned product lifecycle assessments for pharmaceutical packaging. The LCA methodology accounts for pharmaceutical-specific product integrity constraints — meaning it doesn't assume standard eco-design options that would compromise drug safety or regulatory compliance. Outputs feed directly into your corporate GHG footprint and serve as the evidence basis required by PPWR and ESPR auditors.
NHS England's Net Zero Supplier Roadmap requires UK pharma suppliers to disclose GHG emissions and demonstrate a reduction trajectory. Greenly produces GHG Protocol-aligned carbon accounts continuously — not as an annual point-in-time exercise. When an NHS RFP or supplier questionnaire arrives, your data is current and audit-ready. Greenly also exports CDP and EcoVadis responses for parent-group and hospital network scorecards.
Greenly's platform is built around audit-grade traceability: version history per emission factor, document attachment per data point, methodology notes per output, and an auditor read-only access mode. The evidence structure mirrors the documentation standards pharma companies already apply to batch records. Multiple Greenly customers have passed CSRD ESRS E1 third-party audits using data produced on the platform.
Greenly draws from Ecoinvent (the de facto standard for pharma and life sciences), ADEME Base Empreinte (France), DEFRA/BEIS (UK), IEA, IPCC, EPA and much more. Greenly rely on a database of +500k emission factors. Emission factor selection is automated, with full version control. Where a client has a proprietary or client-specified emission factor, Greenly's climate experts integrate it and maintain the audit trail.
Greenly's CSRD module covers the full ESRS E1 disclosure requirements: GHG inventory (Scope 1, 2, and 3), transition plan narrative inputs, climate risk alignment, and third-party audit readiness. For finished-dose manufacturers operating as CSRD Wave 1 or Wave 2 subsidiaries, the module supports both consolidated group reporting and individual entity disclosure. Outputs are structured for direct submission to auditors or integration into the group's CSRD reporting workflow.
Yes. Greenly's supplier engagement module combines a database-first approach (automated sourcing of publicly available supplier data) with configurable questionnaires, automated follow-up, scoring, evidence capture, and full audit trail. For pharma supply chains concentrated in Asia and Eastern Europe — where survey response rates are typically low — this hybrid approach reduces reliance on spend-based secondary data without requiring manual supplier outreach at scale.
